期刊文献+

重组毕赤酵母高密度发酵表达肽抗生素hPAB-β及其抑菌活性初步鉴定 被引量:3

Expression and biological activity analysis of peptide antibiotics hPAB-βin recombinant Pichia pastoris by high-density fermentation
下载PDF
导出
摘要 目的探讨hPAB-β工程菌的高密度发酵方法,鉴定发酵产物中目的肽的活性。方法采用补料分批培养方法,在3.7 L发酵罐中对重组酵母菌进行高密度发酵,温度控制在30℃,pH值范围为4.95~5.05,在菌体湿重达到200~250 g/L后开始诱导,经过约50 h甲醇诱导后结束发酵。对发酵上清进行反相层析、分子筛层析以及反相高效液相色谱纯化,通过抑菌实验对纯化产物进行活性鉴定。结果3次高密度发酵在菌体湿重分别达到235.0 g/L、210 g/L和264.8g/L时进行诱导表达,发酵上清中目标肽的表达量分别达73.7 mg/L、76.6 mg/L和74.3 mg/L。发酵上清通过反相层析、分子筛层析以及反相高效液相色谱纯化,获得重组肽抗生素hPAB-β,该重组蛋白经抑菌实验显示了较好的抑菌活性。结论成功实现了酵母工程菌的高密度发酵,为下一步规模化制备hPAB-β奠定了基础。 To evaluate the expression of hPAB-βin recombinant Pichia pastori by the high density fermentation and the biological activity of hPAB-β.Engineering bacteria was fermented in fed-batch high-density fermentation in a 3.7 L fermentor at temperature 30℃and pH 4.95-5.05.When the wet weight achieved 200-250g/L,engineering bacteria was induced by methanol.After more than 50 hours induction,fermentation was terminated and the supernatant was purified by reverse phase chromatogram,gel filtration chromatogram,and high performance liquid chromatogram.The biological activity was identified by bacteriostasis assay.Engineering bacteria was induced when the wet weight achieved 235.0 g/L,210 g/L and 264.8 g/L in 3 fermentations,and the yields of target peptide were 73.7 mg/L,76.6 mg/L, and 74.3 mg/L in supernatant,respectively.The recombinant peptide hPAB-βpurified from fermentation supernatant showed fine bacteriostasis activity.All data imply that engineering bacteria was fermented in fed-batch high-density fermentation successfully,and which made a foundation for the large-scale production of hPAB-β.
出处 《免疫学杂志》 CAS CSCD 北大核心 2010年第1期6-9,20,共5页 Immunological Journal
基金 全军“十一五”攻关课题(06G075) 重庆市攻关课题(CSTC.2005AB5021)
关键词 肽抗生素hPAB-β 毕赤酵母 高密度发酵 Peptide antibiotics hPAB-β Pichia pastoris High-density fermentation
  • 相关文献

参考文献10

二级参考文献44

  • 1屠益增,屈贤铭,许廷森.家蚕抗菌肽CM_2Ph_1的分离、纯化、结构及其性质的研究[J].中国科学(B辑),1989(5):473-480. 被引量:7
  • 2陈伟.不同来源HBsAg的免疫原性比较(硕士研究生论文)[M].,..
  • 3Boman H G.Peptide antibiotics and their role in innate immunity.Annu Rev Immunol,1995,13:61-92.
  • 4Boman H G.Antibacterial peptides:basic facts and emerging concepts.J Intern Med,2003,254(3):197-215.
  • 5Hancock R E,Patrzykat A.Clinical development of cationic antimicrobial peptides:from natural to novel antibiotics.Curr Drug Targets Infect Disord,2002,2(1):79-83.
  • 6Diamond G.Natures antibiotics:the potential of antimicrobial peptides as new drugs.Biologist(London),2001,48(5):209-212.
  • 7Bals R.Antimicrobial peptides and peptide amtibiotics.Med Klin(Munich),2000,95(9):496-502.
  • 8Nozomi K,Tomoyas A,Hiroshi S,et al.Expression and purification of a small cytokine growth-blocking peptide from armyworm Pseudaletia separate by an optimized fermentation method using the methylotrophic yeast Pichia pastoris.Protein Expression and Purification,2002,25:416-425.
  • 9Dan H,Ake E,Hans B.Insect Immunity:Isolation and structure of cecropin D and fourminor antibacterial components from cecropia pupae.Eur J Biochem,1982,127:207-217.
  • 10Hermann S,Gebhard V J.Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 KDa.Analytical Biochemistry,1987,166:368-379.

共引文献66

同被引文献46

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部